Marienthali Kliinik OÜ

The medical center is at the forefront of research into neurodegenerative disorders, with a particular focus on Alzheimer's disease. The institution is dedicated to exploring innovative treatments for agitation in patients with dementia of the Alzheimer's type, aiming to enhance patient quality of life through advanced therapeutic interventions.

• Alzheimer's Disease
• Agitation Management
• Patient Quality of Life

By conducting cutting-edge clinical trials, the center contributes significantly to the understanding and management of symptoms associated with Alzheimer's, offering hope for improved patient outcomes.

Specializing in the treatment of mood disorders, the medical center is engaged in pioneering research to address Major Depressive Disorder (MDD). The focus is on evaluating the efficacy of novel pharmacological treatments, such as BH-200, to alleviate depressive symptoms and improve mental health outcomes.

• Major Depressive Disorder
• Pharmacological Innovations
• Mental Health Improvement

Through rigorous clinical trials, the center is advancing the field of psychiatry by developing effective treatment strategies that cater to the specific needs of patients with complex mood disorders.